• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化应激在卵巢癌中的作用研究进展。

Insights into the Role of Oxidative Stress in Ovarian Cancer.

机构信息

Department of Obstetrics and Gynecology, Heilongjiang University of Chinese Medicine, Harbin 150040, China.

Department of Obstetrics and Gynecology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China.

出版信息

Oxid Med Cell Longev. 2021 Oct 7;2021:8388258. doi: 10.1155/2021/8388258. eCollection 2021.

DOI:10.1155/2021/8388258
PMID:34659640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8516553/
Abstract

Oxidative stress (OS) arises when the body is subjected to harmful endogenous or exogenous factors that overwhelm the antioxidant system. There is increasing evidence that OS is involved in a number of diseases, including ovarian cancer (OC). OC is the most lethal gynecological malignancy, and risk factors include genetic factors, age, infertility, nulliparity, microbial infections, obesity, smoking, etc. OS can promote the proliferation, metastasis, and therapy resistance of OC, while high levels of OS have cytotoxic effects and induce apoptosis in OC cells. This review focuses on the relationship between OS and the development of OC from four aspects: genetic alterations, signaling pathways, transcription factors, and the tumor microenvironment. Furthermore, strategies to target aberrant OS in OC are summarized and discussed, with a view to providing new ideas for clinical treatment.

摘要

氧化应激(OS)是指当身体受到有害的内源性或外源性因素的侵袭,超过抗氧化系统的承受能力时产生的一种状态。越来越多的证据表明,OS 与许多疾病有关,包括卵巢癌(OC)。OC 是最致命的妇科恶性肿瘤,其危险因素包括遗传因素、年龄、不孕、未婚、微生物感染、肥胖、吸烟等。OS 可以促进 OC 的增殖、转移和治疗耐药性,而高水平的 OS 具有细胞毒性作用,并诱导 OC 细胞凋亡。本综述从遗传改变、信号通路、转录因子和肿瘤微环境四个方面重点探讨了 OS 与 OC 发生发展的关系。此外,还总结和讨论了针对 OC 中异常 OS 的策略,以期为临床治疗提供新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c02f/8516553/7f267925dfa5/OMCL2021-8388258.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c02f/8516553/8f26e8d3a871/OMCL2021-8388258.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c02f/8516553/4f3e55f4122b/OMCL2021-8388258.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c02f/8516553/a87cbd55a5f8/OMCL2021-8388258.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c02f/8516553/26407d5e91ea/OMCL2021-8388258.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c02f/8516553/7f267925dfa5/OMCL2021-8388258.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c02f/8516553/8f26e8d3a871/OMCL2021-8388258.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c02f/8516553/4f3e55f4122b/OMCL2021-8388258.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c02f/8516553/a87cbd55a5f8/OMCL2021-8388258.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c02f/8516553/26407d5e91ea/OMCL2021-8388258.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c02f/8516553/7f267925dfa5/OMCL2021-8388258.005.jpg

相似文献

1
Insights into the Role of Oxidative Stress in Ovarian Cancer.氧化应激在卵巢癌中的作用研究进展。
Oxid Med Cell Longev. 2021 Oct 7;2021:8388258. doi: 10.1155/2021/8388258. eCollection 2021.
2
TPX2 gene silencing inhibits cell proliferation and promotes apoptosis through negative regulation of AKT signaling pathway in ovarian cancer.沉默 TPX2 基因通过负向调控 AKT 信号通路抑制卵巢癌细胞增殖并促进凋亡。
J Cell Biochem. 2018 Sep;119(9):7540-7555. doi: 10.1002/jcb.27065. Epub 2018 Jun 15.
3
NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.NCALD 通过作为卵巢癌细胞中 CX3CL1 的 ceRNA 来影响药物耐药性和预后。
J Cell Biochem. 2020 Nov;121(11):4470-4483. doi: 10.1002/jcb.29670. Epub 2020 Feb 7.
4
Calcium signals and potential therapy targets in ovarian cancer (Review).钙信号与卵巢癌的潜在治疗靶点(综述)。
Int J Oncol. 2023 Nov;63(5). doi: 10.3892/ijo.2023.5573. Epub 2023 Sep 15.
5
Serotonin/HTR1E signaling blocks chronic stress-promoted progression of ovarian cancer.血清素/5-HT1E 信号通路阻断慢性应激促进的卵巢癌进展。
Theranostics. 2021 May 8;11(14):6950-6965. doi: 10.7150/thno.58956. eCollection 2021.
6
Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer.卵巢癌中与总生存期和耐药性潜在相关基因的交叉验证
Oncol Rep. 2017 May;37(5):3084-3092. doi: 10.3892/or.2017.5534. Epub 2017 Mar 27.
7
Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.微小RNA miR-433的过表达通过诱导卵巢癌细胞衰老促进对紫杉醇的耐药性。
Cancer Med. 2015 May;4(5):745-58. doi: 10.1002/cam4.409. Epub 2015 Feb 15.
8
MicroRNA-508 suppresses epithelial-mesenchymal transition, migration, and invasion of ovarian cancer cells through the MAPK1/ERK signaling pathway.微小 RNA-508 通过 MAPK1/ERK 信号通路抑制卵巢癌细胞上皮-间充质转化、迁移和侵袭。
J Cell Biochem. 2018 Sep;119(9):7431-7440. doi: 10.1002/jcb.27052. Epub 2018 May 21.
9
MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.MIEF2 过表达通过重编程卵巢癌细胞葡萄糖代谢促进肿瘤生长和转移。
J Exp Clin Cancer Res. 2020 Dec 14;39(1):286. doi: 10.1186/s13046-020-01802-9.
10
Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling.长链非编码 RNA CHRF 在顺铂耐药卵巢癌中的新作用是通过 miR-10b 诱导的 EMT 和 STAT3 信号传导介导的。
Sci Rep. 2020 Sep 8;10(1):14768. doi: 10.1038/s41598-020-71153-0.

引用本文的文献

1
Unlocking the mitochondrial functional code: unraveling the pathogenesis of ovarian cancer and innovative targets to inhibit malignant behavior.解开线粒体功能密码:揭示卵巢癌发病机制及抑制恶性行为的创新靶点。
J Transl Med. 2025 Jul 24;23(1):819. doi: 10.1186/s12967-025-06840-5.
2
Ovarian Cancer and the Risk of Cataract Episodes: A Nationwide Cohort Study.卵巢癌与白内障发作风险:一项全国性队列研究
In Vivo. 2025 Jul-Aug;39(4):2302-2310. doi: 10.21873/invivo.14026.
3
Hsa-miR-21-5p and Hsa-miR-145-5p Expression: From Normal Tissue to Malignant Changes-Context-Dependent Correlation with Estrogen- and Hypoxia-Vascularization-Related Pathways Genes: A Pilot Study.

本文引用的文献

1
Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the Nrf2 pathway.地奥司明通过激活活性氧物种和抑制 Nrf2 通路诱导卵巢癌细胞凋亡。
Med Oncol. 2021 Apr 3;38(5):54. doi: 10.1007/s12032-021-01501-1.
2
Targeting Nrf2 may reverse the drug resistance in ovarian cancer.靶向Nrf2可能会逆转卵巢癌的耐药性。
Cancer Cell Int. 2021 Feb 17;21(1):116. doi: 10.1186/s12935-021-01822-1.
3
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma.卵巢透明细胞癌中的抗氧化剂与治疗靶点
人源微小RNA-21-5p和人源微小RNA-145-5p的表达:从正常组织到恶性病变——与雌激素及缺氧-血管生成相关通路基因的上下文依赖性关联:一项初步研究
Int J Mol Sci. 2025 May 7;26(9):4461. doi: 10.3390/ijms26094461.
4
Increased risk of young-onset ovarian cancer in women with non-alcoholic fatty liver disease: A nationwide cohort study of 2.3 million women aged 20-39 years.非酒精性脂肪性肝病女性患早发性卵巢癌的风险增加:一项对230万20至39岁女性的全国性队列研究。
Sci Rep. 2025 Apr 25;15(1):14463. doi: 10.1038/s41598-025-99093-7.
5
Association of pre- and post-diagnosis dietary total antioxidant capacity (TAC) and composite dietary antioxidant index (CDAI) with overall survival in patients with ovarian cancer: a prospective cohort study.卵巢癌患者诊断前后饮食总抗氧化能力(TAC)和复合饮食抗氧化指数(CDAI)与总生存期的关联:一项前瞻性队列研究。
J Transl Med. 2025 Jan 30;23(1):134. doi: 10.1186/s12967-024-06041-6.
6
Exploring the innovative application of cerium oxide nanoparticles for addressing oxidative stress in ovarian tissue regeneration.探索氧化铈纳米颗粒在解决卵巢组织再生中的氧化应激方面的创新应用。
J Ovarian Res. 2024 Dec 5;17(1):241. doi: 10.1186/s13048-024-01566-2.
7
The Presence of Ovarian Cancer and the Incidence of Subsequent Open-Angle Glaucoma: A Population-Based Cohort Study.卵巢癌的存在与后续开角型青光眼的发病率:一项基于人群的队列研究。
Cancers (Basel). 2024 Aug 12;16(16):2828. doi: 10.3390/cancers16162828.
8
Multiaction Pt(IV) Complexes: Cytotoxicity in Ovarian Cancer Cell Lines and Mechanistic Studies.多作用 Pt(IV) 配合物:在卵巢癌细胞系中的细胞毒性和机制研究。
Inorg Chem. 2024 Aug 12;63(32):14958-14968. doi: 10.1021/acs.inorgchem.4c01586. Epub 2024 Jul 31.
9
Activity of NAD(P)H-Oxidoreductases in Ovarian Cancer.卵巢癌中NAD(P)H氧化还原酶的活性
Biomedicines. 2024 May 10;12(5):1052. doi: 10.3390/biomedicines12051052.
10
Review of the Potential Role of Ascorbate in the Prevention and Treatment of Gynecological Cancers.维生素C在妇科癌症预防和治疗中潜在作用的综述
Antioxidants (Basel). 2024 May 19;13(5):617. doi: 10.3390/antiox13050617.
Antioxidants (Basel). 2021 Jan 28;10(2):187. doi: 10.3390/antiox10020187.
4
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming.紫杉烷类药物在癌症治疗中的作用、化疗耐药性及其克服。
Drug Resist Updat. 2021 Jan;54:100742. doi: 10.1016/j.drup.2020.100742. Epub 2021 Jan 9.
5
MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS/AKT/mTOR signaling pathway.MIEF2 通过 ROS/AKT/mTOR 信号通路重编程脂质代谢以推动卵巢癌的进展。
Cell Death Dis. 2021 Jan 5;12(1):18. doi: 10.1038/s41419-020-03336-6.
6
Grape polyphenols supplementation for exercise-induced oxidative stress.补充葡萄多酚对抗运动引起的氧化应激。
J Int Soc Sports Nutr. 2021 Jan 7;18(1):3. doi: 10.1186/s12970-020-00395-0.
7
Olive leaf extract impairs mitochondria by pro-oxidant activity in MDA-MB-231 and OVCAR-3 cancer cells.橄榄叶提取物通过 MDA-MB-231 和 OVCAR-3 癌细胞中的促氧化剂活性损害线粒体。
Biomed Pharmacother. 2021 Feb;134:111139. doi: 10.1016/j.biopha.2020.111139. Epub 2020 Dec 24.
8
The Nrf2/PGC1 Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer.Nrf2/PGC1 通路调节抗氧化和蛋白酶体活性改变卵巢癌对顺铂的敏感性。
Oxid Med Cell Longev. 2020 Nov 26;2020:4830418. doi: 10.1155/2020/4830418. eCollection 2020.
9
Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils.应激激活的中性粒细胞衍生的修饰脂质激活休眠肿瘤细胞
Sci Transl Med. 2020 Dec 2;12(572). doi: 10.1126/scitranslmed.abb5817.
10
Celastrol Loaded Nanoparticles With ROS-Response and ROS-Inducer for the Treatment of Ovarian Cancer.具有ROS响应和ROS诱导剂的雷公藤红素纳米粒用于治疗卵巢癌
Front Chem. 2020 Oct 30;8:574614. doi: 10.3389/fchem.2020.574614. eCollection 2020.